Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Travere Therapeutics (TVTX) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 35 quarters since 2012. Compare with TVTX stock chart to see long term trends.

TVTX Stock Compared to Quarterly

TVTX Income Statement

Revenue, Net:68217000
Revenue Per Share:1.11
Cost of Goods & Services Sold:1592000
Selling, General & Admin Expense:36065000
Research & Development Expense:48407000
Total Operating Expenses:99928000
Operating Income:-35596000
Income Taxes:43000
Net Income:-35639000
Earnings Per Share, Basic:-0.59
Shares Outstanding, Basic Avg:61226392

TVTX Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:7873000
Change in Accounts Receiveable:1479000
Net Cash from Operations:32063000
Net Cash from Financing Activities:2414000
Property, Plant & Equipment Purchases:349000
Net Cash from Investing Activities:32520000
Net Change in Cash & Equivalents:67039000

TVTX Balance Sheet

Cash and Cash Equivalents:150327000
Accounts Receivable, Net:13370000
Inventories:6616000
Total Current Assets:579079000
Property, Plant & Equipment, Net:11513000
Total Assets:775075000
Accounts Payable:5830000
Total Short-Term Liabilities:113163000
Total Liabilities:467705000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Ra Capital Management, L.P.
5,614,428 sh
 
$136,150
Armistice Capital, LLC
4,748,000 sh
-1,000,000 sh
-17%
$115,139
$31,276
Blackrock Inc.
4,562,850 sh
-429,675 sh
-9%
$110,648
$37,808
Janus Henderson Group Plc
4,023,074 sh
117,961 sh
3%
$97,561
$40,584
Macquarie Group Ltd
3,951,841 sh
39,428 sh
1%
$95,833
$38,751
Vanguard Group Inc
3,865,481 sh
30,725 sh
1%
$93,738
$37,789
State Street Corp
2,782,323 sh
-671,536 sh
-19%
$67,471
$17,079
Baker Bros. Advisors Lp
2,039,772 sh
1,852,857 sh
991%
$49,464
$46,737
Perceptive Advisors LLC
1,965,555 sh
120,000 sh
7%
$47,665
$20,738
Vr Adviser, LLC
1,732,410 sh
1,732,410 sh
NEW
$42,011
$42,011
Adage Capital Partners Gp, L.L.C.
1,700,000 sh
-1,893,763 sh
-53%
$41,225
-$11,208
Rock Springs Capital Management Lp
1,496,817 sh
2,653 sh
0%
$36,298
$14,498
Renaissance Technologies LLC
1,240,418 sh
-470,904 sh
-28%
$30,080
$5,112
Goldman Sachs Group Inc
1,093,322 sh
-1,363,958 sh
-56%
$26,513
-$9,339
Jacobs Levy Equity Management, Inc
1,032,398 sh
241,467 sh
31%
$25,036
$13,496
Geode Capital Management, LLC
983,978 sh
-21,461 sh
-2%
$23,861
$9,192
JPMorgan Chase & Co
976,140 sh
-80,384 sh
-8%
$23,672
$8,257
Dimensional Fund Advisors LP
970,470 sh
-176,356 sh
-15%
$23,533
$6,800
Bank Of America Corp /De/
955,430 sh
-717,055 sh
-43%
$23,169
-$1,231
Citadel Advisors LLC
802,370 sh
737,370 sh
1134%
$19,457
$18,509

Data imported from Travere Therapeutics Inc SEC filings. Check original filings before making any investment decision.